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Background: In patients with hypoplastic left heart syndrome status-post Norwood procedure with right ventricle-pulmonary artery (RV-PA) shunt, 
the shunt can be either removed or left intact at the time of the stage II procedure. We examined the effects of an intact RV-PA shunt on pulmonary 
artery growth and on clinical outcomes related to stage II.
Methods: Our surgical database was queried to identify patients who underwent Norwood with RV-PA shunt from 2005-2010. Those who then went 
on to stage II at our institution were included in the study. Data collected included: catheterization data, echocardiographic data, post-operative 
outcome variables, and mortality. Pulmonary artery size was measured at pre-stage II and pre-Fontan catheterizations using both the Nakata index 
and McGoon ratio. Statistical comparisons were made between the groups using independent measure analyses as appropriate, and mortality was 
assessed using Kaplan-Meier survival with the log-rank test.
Results: Sixty-eight patients met inclusion criteria for the study. Of these, 48 had the RV-PA shunt removed at the time of stage II (Group 1), and 
20 had the shunt left intact (Group 2). There were no differences in pre-stage II hemodynamics or pulmonary artery size. Post-operative outcomes for 
stage II were similar, except for higher discharge oxygen saturation in Group 2 (84.5 versus 79.6%, p=0.0001). There were no differences in duration 
of chest tube drainage, length of hospital stay, or need for unplanned interventions after stage II. At the pre-Fontan cath, SVC mean pressures were 
higher in Group 2 (13.6 versus 11.5mmHg, p=0.02), and more patients in Group 2 had veno-venous collaterals closed (40% vs 9.7%, p=0.047). 
There was increased pulmonary artery growth between the pre-stage II and pre-Fontan catheterizations in Group 2 using both the Nakata index 
(+148.5 versus -52.4 mm2/m2, p=0.01) and McGoon ratio (+0.36 versus +0.01, p=0.01). There was no difference in mortality between the groups.
Conclusions: Patients with an RV-PA shunt left intact following stage II have increased pulmonary artery growth compared to patients with the 
shunt removed, with no increased risk of complications or change in mortality.
